Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Total Liabilities Summary of Blau Farmacêutica S.A.

Blau Farmacêutica S.A.'s latest annual total liabilities in 2023 was 1.05 Billion BRL , up 55.37% from previous year.
Blau Farmacêutica S.A.'s latest quarterly total liabilities in 2024 Q1 was 1.14 Billion BRL , up 8.5% from previous quarter.
Blau Farmacêutica S.A. reported annual total liabilities of 681.11 Million BRL in 2022, down -1.74% from previous year.
Blau Farmacêutica S.A. reported annual total liabilities of 693.16 Million BRL in 2021, down -34.07% from previous year.
Blau Farmacêutica S.A. reported quarterly total liabilities of 1.06 Billion BRL for 2024 Q2, down -7.33% from previous quarter.
Blau Farmacêutica S.A. reported quarterly total liabilities of 1.1 Billion BRL for 2023 Q3, up 75.34% from previous quarter.

Annual Total Liabilities Chart of Blau Farmacêutica S.A. (2023 - 2015)

Historical Annual Total Liabilities of Blau Farmacêutica S.A. (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	1.05 Billion BRL	55.37%
2022	681.11 Million BRL	-1.74%
2021	693.16 Million BRL	-34.07%
2020	1.05 Billion BRL	122.41%
2019	472.68 Million BRL	27.47%
2018	370.82 Million BRL	62.9%
2017	227.63 Million BRL	4.31%
2016	218.23 Million BRL	-0.6%
2015	219.54 Million BRL	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	1.14 Billion BRL	8.5%
2024 Q2	1.06 Billion BRL	-7.33%
2023 Q3	1.1 Billion BRL	75.34%
2023 FY	1.05 Billion BRL	55.37%
2023 Q1	671.82 Million BRL	-1.36%
2023 Q4	1.05 Billion BRL	-4.22%
2023 Q2	630.15 Million BRL	-6.2%
2022 Q2	664.24 Million BRL	4.51%
2022 FY	681.11 Million BRL	-1.74%
2022 Q4	681.11 Million BRL	-0.22%
2022 Q3	682.62 Million BRL	2.77%
2022 Q1	635.59 Million BRL	-8.31%
2021 Q4	693.16 Million BRL	-3.92%
2021 Q2	760.17 Million BRL	-32.25%
2021 Q1	1.12 Billion BRL	6.74%
2021 FY	693.16 Million BRL	-34.07%
2021 Q3	721.47 Million BRL	-5.09%
2020 FY	1.05 Billion BRL	122.41%
2020 Q4	1.05 Billion BRL	9.72%
2020 Q3	958.1 Million BRL	-1.97%
2020 Q2	977.38 Million BRL	94.0%
2020 Q1	503.81 Million BRL	6.58%
2019 Q1	385.74 Million BRL	4.02%
2019 Q2	434.34 Million BRL	12.6%
2019 Q4	472.68 Million BRL	-5.75%
2019 Q3	501.54 Million BRL	15.47%
2019 FY	472.68 Million BRL	27.47%
2018 Q4	370.82 Million BRL	0.0%
2018 FY	370.82 Million BRL	62.9%
2017 FY	227.74 Million BRL	4.31%
2016 FY	218.23 Million BRL	-0.6%
2015 FY	218.91 Million BRL	0.0%

Peer Total Liabilities Comparison of Blau Farmacêutica S.A.

Name	Total Liabilities	Total Liabilities Difference
Hypera S.A.	12.99 Billion BRL	91.854%